0.40 / 0.71 %
1.90 %
Close in USDToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Oct 09 2015 21:00 BST.


On Friday, AbbVie Inc (ABBV:NYQ) closed at 55.64, 7.25% above its 52-week low of 51.88, set on Sep 29, 2015.

52-week range
Sep 29 2015
Jul 21 2015
Markit short selling activity
Day high56.50
Day low55.47
Previous close56.04
Average volume9.82m
Shares outstanding1.66bn
Free float1.63bn
P/E (TTM)43.52
Market cap92.10bn USD
Annual div (IAD)2.04 USD
Annual div yield (IAD)3.64%
Div ex-dateJul 13 2015
Div pay-dateAug 14 2015
Next div ex-dateOct 13 2015
Next div pay-dateNov 16 2015
Data delayed at least 15 minutes, as of Oct 09 2015 21:00 BST.
Last IC View
The last IC recommendation on AbbVie Inc shares was Hold at 4,801 on 16 Jul 2014
Read the full article

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
AbbVie Inc-0.32 %-6.11 %-10.26 %-1.90 %0.00%
S&P 500 INDEX+3.26 %+3.75 %-4.15 %+4.50 %+72.93 %
USA/HEALTH CARE-0.10 %-3.08 %-8.92 %+8.24 %+55.63 %
USA/PHARMACEUTICALS-0.27 %-0.79 %-8.75 %+4.87 %+46.68 %
Data delayed at least 15 minutes, as of Oct 09 2015 21:00 BST.
© Thomson Reuters Click for restrictions.

All markets data located on is subject to the FT Terms & Conditions.

All content on is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.